Hepatocyte-derived Exosomal MiR-27a Activateshepatic Stellate Cells Through the Inhibitionof PINK1-mediated Mitophagy in MAFLD

Overview

Journal Mol Ther Nucleic Acids

Publisher Cell Press

Date 2021 Dec 2

PMID 34853724

Citations 18

Authors

Xin Luo

Zi-Xin Xu

Jun-Cheng Wu

Sheng-Zheng Luo

Ming-Yi Xu

Affiliations

Soon will be listed here.

Abstract

The role of exosome-mediated mitophagy in the crosstalk between hepatocytes (HCs) and hepatic stellate cells (HSCs) in metabolic-associated fatty liver disease (MAFLD) remains unknown. Serum exosomal miR-27a levels were markedly increased and positively correlated with liver fibrosis in MAFLD patients and mice. Exosomal miR-27a was released from lipotoxic HCs and specifically transmitted to recipient-activated HSCs. PINK1, the key target of miR-27a, primarily mediates mitophagy. Overexpression of miR-27a or knockdown of PINK1 or lipotoxic HC-exosomal miR-27a impaired mitochondria (inhibiting mitophagy, respiration, membrane potential, and transcription while promoting reactive oxygen species production) in activated HSCs and stimulated HSC-derived fibroblasts (promoting activation and proliferation while inhibiting autophagy). High exosomal miR-27a serum levels and a lack of hepatic PINK1-mediated mitophagy were directly related to liver fibrosis in MAFLD mice. Lipotoxic HC exosome transplantation aggravated the degree of PINK1-mediated mitophagy suppression, steatohepatitis, lipidosis, and fibrosis in the livers of MAFLD mice with cirrhosis. Both and , exosomes derived from miR-27a-knockdown HCs could not facilitate the abovementioned deteriorating effects. In conclusion, lipotoxic HC-exosomal miR-27a plays a pivotal role in inhibiting mitophagy and in promoting MAFLD-related liver fibrosis by negatively regulating PINK1 expression.

Citing Articles

Macronutrient Modulation in Metabolic Dysfunction-Associated Steatotic Liver Disease-the Molecular Role of Fatty Acids compared with Sugars in Human Metabolism and Disease Progression.

Mullin S, Kelly A, Ni Chathail M, Norris S, Shannon C, Roche H Adv Nutr. 2025; 16(3):100375.

PMID: 39842721 PMC: 11849631. DOI: 10.1016/j.advnut.2025.100375.

Novel insights into the role of immunomodulatory extracellular vesicles in the pathogenesis of liver fibrosis.

Li J, Yuan Y, Fu Q, Chen M, Liang H, Chen X Biomark Res. 2024; 12(1):119.

PMID: 39396032 PMC: 11470730. DOI: 10.1186/s40364-024-00669-8.

Sinusoidal communication in chronic liver disease.

Gibert-Ramos A, Andres-Rozas M, Pasto R, Alfaro-Retamero P, Guixe-Muntet S, Gracia-Sancho J Clin Mol Hepatol. 2024; 31(1):32-55.

PMID: 39355871 PMC: 11791556. DOI: 10.3350/cmh.2024.0734.

Exosome prospects in the diagnosis and treatment of non-alcoholic fatty liver disease.

Tamimi A, Javid M, Sedighi-Pirsaraei N, Mirdamadi A Front Med (Lausanne). 2024; 11:1420281.

PMID: 39144666 PMC: 11322140. DOI: 10.3389/fmed.2024.1420281.

Linking fatty liver diseases to hepatocellular carcinoma by hepatic stellate cells.

Chen L, Ye X, Yang L, Zhao J, You J, Feng Y J Natl Cancer Cent. 2024; 4(1):25-35.

PMID: 39036388 PMC: 11256631. DOI: 10.1016/j.jncc.2024.01.002.

References

Li S, Lin Q, Shao X, Zhu X, Wu J, Wu B . Drp1-regulated PARK2-dependent mitophagy protects against renal fibrosis in unilateral ureteral obstruction. Free Radic Biol Med. 2019; 152:632-649. DOI: 10.1016/j.freeradbiomed.2019.12.005. View

Bueno M, Lai Y, Romero Y, Brands J, St Croix C, Kamga C . PINK1 deficiency impairs mitochondrial homeostasis and promotes lung fibrosis. J Clin Invest. 2015; 125(2):521-38. PMC: 4319413. DOI: 10.1172/JCI74942. View

Ding Q, Xie X, Wang M, Yin J, Tian J, Jiang X . The role of the apoptosis-related protein BCL-B in the regulation of mitophagy in hepatic stellate cells during the regression of liver fibrosis. Exp Mol Med. 2019; 51(1):1-13. PMC: 6329697. DOI: 10.1038/s12276-018-0199-6. View

Angulo P, Kleiner D, Dam-Larsen S, Adams L, Bjornsson E, Charatcharoenwitthaya P . Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease. Gastroenterology. 2015; 149(2):389-97.e10. PMC: 4516664. DOI: 10.1053/j.gastro.2015.04.043. View

Masyuk A, Masyuk T, LaRusso N . Exosomes in the pathogenesis, diagnostics and therapeutics of liver diseases. J Hepatol. 2013; 59(3):621-5. PMC: 3831338. DOI: 10.1016/j.jhep.2013.03.028. View

Meira Martins L, Vieira M, Ilha M, de Vasconcelos M, Biehl H, Lima D . The interplay between apoptosis, mitophagy and mitochondrial biogenesis induced by resveratrol can determine activated hepatic stellate cells death or survival. Cell Biochem Biophys. 2014; 71(2):657-72. DOI: 10.1007/s12013-014-0245-5. View

Tsubouchi K, Araya J, Kuwano K . PINK1-PARK2-mediated mitophagy in COPD and IPF pathogeneses. Inflamm Regen. 2018; 38:18. PMC: 6199723. DOI: 10.1186/s41232-018-0077-6. View

Lee Y, Kim S, Ko E, Lee J, Yi H, Yoo Y . Exosomes derived from palmitic acid-treated hepatocytes induce fibrotic activation of hepatic stellate cells. Sci Rep. 2017; 7(1):3710. PMC: 5473841. DOI: 10.1038/s41598-017-03389-2. View

Ge S, Wang X, Xie J, Yi X, Liu F . Deep sequencing analysis of microRNA expression in porcine serum-induced hepatic fibrosis rats. Ann Hepatol. 2014; 13(4):439-49. View

10.

Yu X, Hao M, Liu Y, Ma X, Lin W, Xu Q . Liraglutide ameliorates non-alcoholic steatohepatitis by inhibiting NLRP3 inflammasome and pyroptosis activation via mitophagy. Eur J Pharmacol. 2019; 864:172715. DOI: 10.1016/j.ejphar.2019.172715. View

11.

Kobayashi K, Araya J, Minagawa S, Hara H, Saito N, Kadota T . Involvement of PARK2-Mediated Mitophagy in Idiopathic Pulmonary Fibrosis Pathogenesis. J Immunol. 2016; 197(2):504-16. DOI: 10.4049/jimmunol.1600265. View

12.

Ekstedt M, Hagstrom H, Nasr P, Fredrikson M, Stal P, Kechagias S . Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up. Hepatology. 2014; 61(5):1547-54. DOI: 10.1002/hep.27368. View

13.

Denardin C, Martins L, Parisi M, Vieira M, Terra S, Barbe-Tuana F . Autophagy induced by purple pitanga (Eugenia uniflora L.) extract triggered a cooperative effect on inducing the hepatic stellate cell death. Cell Biol Toxicol. 2016; 33(2):197-206. DOI: 10.1007/s10565-016-9366-5. View

14.

Ibrahim S, Hirsova P, Gores G . Non-alcoholic steatohepatitis pathogenesis: sublethal hepatocyte injury as a driver of liver inflammation. Gut. 2018; 67(5):963-972. PMC: 5889737. DOI: 10.1136/gutjnl-2017-315691. View

15.

Wu H, Chen G, Wang J, Deng M, Yuan F, Gong J . TIM-4 interference in Kupffer cells against CCL4-induced liver fibrosis by mediating Akt1/Mitophagy signalling pathway. Cell Prolif. 2019; 53(1):e12731. PMC: 6985653. DOI: 10.1111/cpr.12731. View

16.

Povero D, Panera N, Eguchi A, Johnson C, Papouchado B, Horcel L . Lipid-induced hepatocyte-derived extracellular vesicles regulate hepatic stellate cell via microRNAs targeting PPAR-γ. Cell Mol Gastroenterol Hepatol. 2016; 1(6):646-663.e4. PMC: 4714359. DOI: 10.1016/j.jcmgh.2015.07.007. View

17.

Zhang X, Zhou J, Peng D, Hua F, Li K, Yu J . Disrupting the TRIB3-SQSTM1 interaction reduces liver fibrosis by restoring autophagy and suppressing exosome-mediated HSC activation. Autophagy. 2019; 16(5):782-796. PMC: 7144866. DOI: 10.1080/15548627.2019.1635383. View

18.

Lemoinne S, Thabut D, Housset C, Moreau R, Valla D, Boulanger C . The emerging roles of microvesicles in liver diseases. Nat Rev Gastroenterol Hepatol. 2014; 11(6):350-61. DOI: 10.1038/nrgastro.2014.7. View

19.

Devhare P, Sasaki R, Shrivastava S, Di Bisceglie A, Ray R, Ray R . Exosome-Mediated Intercellular Communication between Hepatitis C Virus-Infected Hepatocytes and Hepatic Stellate Cells. J Virol. 2017; 91(6). PMC: 5331806. DOI: 10.1128/JVI.02225-16. View

20.

Teimouri M, Hosseini H, Shabani M, Koushki M, Noorbakhsh F, Meshkani R . Inhibiting miR-27a and miR-142-5p attenuate nonalcoholic fatty liver disease by regulating Nrf2 signaling pathway. IUBMB Life. 2020; 72(3):361-372. DOI: 10.1002/iub.2221. View